DK0900077T3 - Anvendelse af en toremifene-metabolit til sænkning af serumcholesterolspejlet - Google Patents

Anvendelse af en toremifene-metabolit til sænkning af serumcholesterolspejlet

Info

Publication number
DK0900077T3
DK0900077T3 DK97906196T DK97906196T DK0900077T3 DK 0900077 T3 DK0900077 T3 DK 0900077T3 DK 97906196 T DK97906196 T DK 97906196T DK 97906196 T DK97906196 T DK 97906196T DK 0900077 T3 DK0900077 T3 DK 0900077T3
Authority
DK
Denmark
Prior art keywords
pct
cholesterol levels
serum cholesterol
lowering serum
sec
Prior art date
Application number
DK97906196T
Other languages
Danish (da)
English (en)
Inventor
Pirkko Haerkoenen
Tatu Miettinen
Eero Maentylae
Lauri Kangas
Michael Degregorio
Original Assignee
Orion Corp
Michael Degregorio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp, Michael Degregorio filed Critical Orion Corp
Application granted granted Critical
Publication of DK0900077T3 publication Critical patent/DK0900077T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK97906196T 1996-03-04 1997-03-04 Anvendelse af en toremifene-metabolit til sænkning af serumcholesterolspejlet DK0900077T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9604577.8A GB9604577D0 (en) 1996-03-04 1996-03-04 Serum cholesterol lowering agent
PCT/FI1997/000140 WO1997032574A1 (fr) 1996-03-04 1997-03-04 Agent abaissant le taux de cholesterol dans le serum

Publications (1)

Publication Number Publication Date
DK0900077T3 true DK0900077T3 (da) 2002-03-25

Family

ID=10789817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97906196T DK0900077T3 (da) 1996-03-04 1997-03-04 Anvendelse af en toremifene-metabolit til sænkning af serumcholesterolspejlet

Country Status (13)

Country Link
US (1) US6037379A (fr)
EP (1) EP0900077B1 (fr)
JP (1) JP4113583B2 (fr)
AT (1) ATE212832T1 (fr)
AU (1) AU708336B2 (fr)
CA (1) CA2248032C (fr)
DE (1) DE69710326T2 (fr)
DK (1) DK0900077T3 (fr)
ES (1) ES2171889T3 (fr)
GB (1) GB9604577D0 (fr)
NZ (1) NZ331624A (fr)
PT (1) PT900077E (fr)
WO (1) WO1997032574A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803521D0 (en) 1998-02-19 1998-04-15 Orion Yhtymo Oy New compounds and pharmaceutical compositions thereof
SI1235776T1 (sl) * 1999-11-16 2006-06-30 Hormos Medical Corp Trifenilalkenski derivati in njihova uporaba kot selektivni estrogenski receptorski modulatorji
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
CA2565134C (fr) 2004-05-04 2013-05-21 Veli-Matti Lehtola Formulations orales d'ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
CN101336227A (zh) * 2005-11-28 2008-12-31 Gtx公司 核受体结合剂
EP2029128B1 (fr) 2006-05-22 2015-08-05 Hormos Medical Ltd. Procédé de traitement d'une prostatite chronique non bactérienne par des modulateurs sélectifs des récepteurs des strogènes ou par des inhibiteurs de l'aromatase
WO2008099060A2 (fr) * 2007-02-14 2008-08-21 Hormos Medical Ltd Procédés de préparation de fispémifène à partir d'ospémifène
MX2009008660A (es) 2007-02-14 2009-10-13 Hormos Medical Ltd Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
US20150321983A1 (en) * 2012-10-19 2015-11-12 Fermion Oy A process for the preparation of ospemifene
WO2014060639A1 (fr) 2012-10-19 2014-04-24 Fermion Oy Procédé pour la préparation d'ospémifène
ES2717546T3 (es) 2014-12-29 2019-06-21 Olon Spa Proceso para la preparación de ospemifeno y fispemifeno
WO2016110805A1 (fr) * 2015-01-09 2016-07-14 Glenmark Pharmaceuticals Limited Procédé de préparation d'ospémifène
AU2016229086B2 (en) 2015-03-10 2018-12-06 Shionogi Inc. Solid dispersions
GR1009542B (el) 2018-04-25 2019-06-07 Φαρματεν Α.Β.Ε.Ε. Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives

Also Published As

Publication number Publication date
NZ331624A (en) 2001-03-30
JP4113583B2 (ja) 2008-07-09
AU708336B2 (en) 1999-08-05
PT900077E (pt) 2002-07-31
DE69710326T2 (de) 2002-08-22
JP2000506155A (ja) 2000-05-23
EP0900077B1 (fr) 2002-02-06
GB9604577D0 (en) 1996-05-01
ATE212832T1 (de) 2002-02-15
US6037379A (en) 2000-03-14
EP0900077A1 (fr) 1999-03-10
CA2248032A1 (fr) 1997-09-12
ES2171889T3 (es) 2002-09-16
WO1997032574A1 (fr) 1997-09-12
CA2248032C (fr) 2006-11-07
AU2096897A (en) 1997-09-22
DE69710326D1 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
DK0900077T3 (da) Anvendelse af en toremifene-metabolit til sænkning af serumcholesterolspejlet
PT799209E (pt) Novas sulfonamidas
DE69512930D1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
SE9601421D0 (sv) New composition
FI970920A (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
SE9600073D0 (sv) Multiple unit dosage form
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
BR0110420A (pt) Agonistas muscarìnicos
NO970067L (no) Nytt farmasöytisk preparat for smertebehandling
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
DK0907639T3 (da) Polymorfe forbindelser
PL320167A1 (en) 2,2-dichloroalkanocarboxylic acids, method of obtaining them and therapeutic agents containing such compounds and their application in treating insulin immunity
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
AU1264295A (en) Anatomical and biological preservative and improved embalming composition and method
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
BR9509970A (pt) Composto
MXPA01012632A (es) Agentes para la anestesia dermica.
DK0837706T3 (da) Influsionspumpe til medicinske væsker
DE69736945D1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
HUP0101354A2 (hu) E-2-[4-(4-klór-1,2-difenil-1-butenil)-fenoxi]-etanol észterei, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
EE04658B1 (et) Pridasinooni derivaadi uus kasutusv?imalus
ATE216695T1 (de) VON INDOL ABGELEITETE AROMATISCHE ETHER ALS ß5HT1-LIKEß LIGANDEN
KR960702456A (ko) 4-(p-플로오로페닐)-3-[(3,4-(메틸렌디옥시)페녹시)메틸]피페리딘의 n-p-할로벤조일메틸 유도체(n-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine)
DE69213660D1 (de) Verwendung von 1-(beta-d-arabinofuranosyl)-5-propynyluracil zur senkung des serumcholesterins
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.